Luvadaxistat
6-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,2-dihydropyridazine-3,4-dione
Molecular Identity
Luvadaxistat
6-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,2-dihydropyridazine-3,4-dione
PubChem CID: 71270546
2D Structure
Properties
C13H11F3N2O2
Molecular Formula
284.23
Molecular Weight
g/mol
284.0773
Exact Mass
Da
2.7
XLogP
Drug-like (Lipinski: < 5)
58.2
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
6
H-Bond Acceptors
424
Complexity
SMILES
Canonical SMILES
SMILES: C1=CC(=CC=C1CCC2=CC(=O)C(=O)NN2)C(F)(F)FIsomeric SMILES
SMILES: C1=CC(=CC=C1CCC2=CC(=O)C(=O)NN2)C(F)(F)FSynonyms(20)
LuvadaxistatTAK-831Luvadaxistat [USAN]76IC00YRVRUNII-76IC00YRVRTAK8314-Hydroxy-6-{2-[4-(trifluoromethyl)phenyl]ethyl}pyridazin-3(2H)-oneLUVADAXISTAT [INN]LUVADAXISTAT [WHO-DD]4-Hydroxy-6-(2-(4-(trifluoromethyl)phenyl)ethyl)pyridazin-3(2H)-one4-HYDROXY-6-(2-(4-(TRIFLUOROMETHYL)PHENYL)ETHYL)-2,3-DIHYDROPYRIDAZIN-3-ONERefChem:1544361425511-32-5CHEMBL2338801WHO 11254
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Luvadaxistat
Loading drug network...